Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome
4.8 (78) · $ 10.00 · In stock
media.springer/full/springer-static/imag
Frontiers Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
Gastrointestinal Neuroendocrine Tumors and the Carcinoid Syndrome
Telotristat etiprate, a novel inhibitor of serotonin synthesis for
Fibrosis and carcinoid syndrome: from causation to future therapy
Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies
Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea
Complications from carcinoid syndrome: review of the current evidence - ecancer
Carcinoid syndrome and neuroendocrine tumours - ScienceDirect
Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review
Inhibition of Peripheral Synthesis of Serotonin as a New Target in
Surgery as a Principle and Technical Consideration for Primary
Irritable bowel syndrome - Wikipedia
Drugs for constipation and diarrhea
